"Prevalence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
| Descriptor ID |
D015995
|
| MeSH Number(s) |
E05.318.308.985.525.750 N01.224.935.597.750 N06.850.505.400.975.525.750 N06.850.520.308.985.525.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prevalence".
Below are MeSH descriptors whose meaning is more specific than "Prevalence".
This graph shows the total number of publications written about "Prevalence" by people in this website by year, and whether "Prevalence" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 16 | 16 |
| 1997 | 0 | 12 | 12 |
| 1998 | 0 | 12 | 12 |
| 1999 | 0 | 19 | 19 |
| 2000 | 0 | 17 | 17 |
| 2001 | 0 | 19 | 19 |
| 2002 | 0 | 22 | 22 |
| 2003 | 0 | 35 | 35 |
| 2004 | 0 | 26 | 26 |
| 2005 | 0 | 48 | 48 |
| 2006 | 0 | 44 | 44 |
| 2007 | 0 | 58 | 58 |
| 2008 | 0 | 48 | 48 |
| 2009 | 0 | 56 | 56 |
| 2010 | 0 | 74 | 74 |
| 2011 | 1 | 80 | 81 |
| 2012 | 0 | 88 | 88 |
| 2013 | 0 | 86 | 86 |
| 2014 | 0 | 90 | 90 |
| 2015 | 0 | 98 | 98 |
| 2016 | 0 | 96 | 96 |
| 2017 | 0 | 108 | 108 |
| 2018 | 0 | 103 | 103 |
| 2019 | 0 | 107 | 107 |
| 2020 | 1 | 116 | 117 |
| 2021 | 1 | 81 | 82 |
| 2022 | 0 | 64 | 64 |
| 2023 | 0 | 41 | 41 |
| 2024 | 0 | 71 | 71 |
| 2025 | 0 | 71 | 71 |
| 2026 | 0 | 11 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prevalence" by people in Profiles.
-
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus. Clin Infect Dis. 2026 Mar 17; 82(3):e561-e570.
-
Economic and humanistic burden of chronic liver diseases in the United States. Expert Rev Pharmacoecon Outcomes Res. 2026 Mar; 26(3):379-387.
-
Impact of Hepatitis C screening and treatment among incarcerated populations in Alberta, Canada on population-level Hepatitis C elimination efforts. Int J Drug Policy. 2026 Apr; 150:105201.
-
A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions. J Clin Invest. 2026 Mar 16; 136(6).
-
Pediatric Diabetes Prevalence Among Medicaid Beneficiaries. JAMA Netw Open. 2026 Feb 02; 9(2):e2560507.
-
Psychoactive Medication Use in Pediatric Heart Transplant Recipients: An Assessment of Prevalence, Risk Factors, and Outcomes. Pediatr Transplant. 2026 Feb; 30(2):e70272.
-
Does presence of hip dysplasia affect the prevalence and location of cam morphologies in pediatric hip pain patients? Clin Imaging. 2026 Mar; 131:110731.
-
Association of Depression With Inferior Amputation-Free Survival in Chronic Limb-Threatening Ischemia. J Surg Res. 2026 Feb; 318:146-153.
-
Prevalence and clinical characteristics of Lynch syndrome-associated adrenocortical carcinoma. Endocr Relat Cancer. 2026 Jan 01; 33(1).
-
Burden of Central Nervous System Cancer in the United States, 1990-2021. JAMA Neurol. 2026 Jan 01; 83(1):35-48.